Suppr超能文献

肽类作为诊断、治疗和治疗诊断工具:进展和未来挑战。

Peptides as Diagnostic, Therapeutic, and Theranostic Tools: Progress and Future Challenges.

机构信息

Department of Microbiology, Panjab University, Chandigarh, India.

Indian Institute of Technology Ropar, Rupnagar, Punjab, India.

出版信息

Crit Rev Ther Drug Carrier Syst. 2022;40(1):49-100. doi: 10.1615/CritRevTherDrugCarrierSyst.2022040322.

Abstract

Peptides are emerging as a promising candidate for therapeutic as well as diagnostic applications within the domain of clinical and scientific research. They are recognized for being highly selective, sensitive and efficacious with minimal or no toxicity. Small size, non-immunogenicity, ease of synthesis and huge scope of modification are some of the well-established properties of peptides, which make them an excellent alternative to not only small drug molecules but also to protein-based biopharmaceuticals such as antibodies and enzymes. The attractive pharmacological profile and intrinsic properties of peptides also make them an interesting diagnostic tool for imaging at the molecular and cellular levels. Molecular imaging coupled with targeted therapy using peptides as theranostics is a two-edged sword. Besides, traditional peptide formats, multifunctional newer peptide designs with improved pharmacokinetics and targetability are also being explored presently. In this review, we come up with a comprehensive summary of the latest progress on peptides and their potential applications in therapeutics and diagnosis for infectious and non-infectious diseases. The last part of the review discusses suitable carrier systems for the delivery of peptides along with highlighting the future challenges.

摘要

肽在临床和科学研究领域的治疗和诊断应用中作为一种有前途的候选物而崭露头角。它们具有高度的选择性、敏感性和有效性,同时毒性最小或没有毒性。肽的一些既定特性,如体积小、非免疫原性、易于合成和广泛的修饰范围,使它们不仅成为小分子药物的理想替代品,而且成为抗体和酶等基于蛋白质的生物制药的理想替代品。肽具有吸引人的药理学特性和内在特性,因此也成为在分子和细胞水平进行成像的有趣诊断工具。使用肽作为治疗和诊断的分子成像与靶向治疗是一把双刃剑。此外,目前还在探索具有改善药代动力学和靶向性的传统肽结构形式的多功能新型肽设计。在这篇综述中,我们全面总结了肽的最新进展及其在传染病和非传染性疾病的治疗和诊断中的潜在应用。综述的最后一部分讨论了肽的合适载体系统的传递,并强调了未来的挑战。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验